Condition: Tricuspid Valve Regurgitation · Tricuspid Valve Insufficiency · Tricuspid Valve Disease · Sponsor: Jiangsu Trulive Medical Co., Ltd
Pivotal trial to evaluate the safety and effectiveness of the TruGamma tricuspid valve replacement system
This description comes directly from the study's public registry record.
Yuxiao Guo · +86 18221025921 · kate.g@trulive.cn
Always discuss trial participation with your own doctor first.
| Cardiovascular Institute & Fuwai Hospital, Chinese Academy of Medical Sciences | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07691307